0DU247Z
Supplement Esophagus, Middle to No Qualifier with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | D Gastrointestinal System |
| Operation | U Supplement |
| Body Part | 2 Esophagus, Middle |
| Approach | 4 Percutaneous Endoscopic |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures add biological or synthetic material to reinforce or augment a gastrointestinal structure that remains in place, rather than removing or replacing it. The most familiar example is hernia repair using mesh, where the natural tissue defect is closed and then bolstered with a synthetic patch to reduce the chance of recurrence, but the category also includes reinforcement of a weakened rectal wall or augmentation of tissue around a stoma to improve support.
This approach is chosen when the underlying organ is structurally sound enough to remain but needs extra strength or bulk to function reliably going forward. It differs fundamentally from procedures that cut away diseased tissue, since the native anatomy stays intact and the added material works alongside it rather than substituting for it.
Anatomy & Axis Detail
Esophagus, Middle
The mid-esophagus lies within the posterior mediastinum behind the trachea and adjacent to the aorta, a segment prone to weakening after resection of a tumor, repair of a traction diverticulum, or long-standing reflux injury. Supplement in this location involves placing graft material or mesh against the existing esophageal wall to reinforce it structurally, distinct from replacing the segment outright. Surgeons may use this approach to buttress a suture line elsewhere in the chest, close a chronic fistula tract, or shore up tissue thinned by radiation for esophageal cancer. Because the thoracic esophagus has no serosal layer and heals less robustly than bowel elsewhere in the gut, added material here plays an outsized role in preventing leak, and documentation should specify the graft type and the exact portion of mid-esophagus reinforced.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
Coders should confirm that the operative note describes material being added to reinforce or augment existing tissue that was not removed, with the specific material named, such as polypropylene mesh or a biologic graft. Supplement frequently appears alongside Repair in hernia surgery, and the two must be sequenced or combined correctly depending on whether the defect closure and reinforcement are described as a single combined objective or separate steps. A common error is coding a mesh-reinforced repair purely as Repair, omitting the Supplement component, or conversely coding Supplement when the mesh was actually used to bridge a defect where tissue was removed, which would instead point toward Replacement. Documentation should also clarify the approach, since mesh placement can occur open, laparoscopically, or via a percutaneous endoscopic technique.